Skip to content
Third-party HPLC + mass spec on every lot
Verified — all release criteria met
releasedCurrent lot

Certificate of analysis

TB-500

Lot CP-TB500-2606A · 5 mg

99.65 %

HPLC purity

Spec ≥ 99.0 %

84.5 %

Net peptide content

By amino acid analysis

< 0.61

Endotoxin (EU/mg)

Spec < 5.0 EU/mg

Provenance

Testing laboratory
Colmaric Analyticals
Accreditation
ISO/IEC 17025:2017
Country of synthesis
United States
Manufactured
Jun 15, 2026
Release tested
Jun 24, 2026 (3 months ago)
Retest date
Jun 14, 2028
CAS number
77591-33-4
Molecular formula
C37H67N9O12
Theoretical mass
861.99 Da
Observed mass (LC-MS)
862.34 Da (Δ 0.35 Da)

Assay results

Every line the release panel ran for this lot, with the method, the acceptance criterion and the measured value — not a pass mark alone.

Certificate of analysis — assay results
MethodParameterSpecificationResult
RP-HPLC (UV 214 nm)Purity (area %)≥ 99.0 %99.65 %Pass
LC-MS (ESI+)Identity — observed mass861.99 ± 1.0 Da862.34 DaPass
Amino acid analysisNet peptide content≥ 80.0 %84.5 %Pass
Karl FischerWater content≤ 8.0 %2.69 %Pass
Ion chromatographyResidual TFA≤ 1.0 %0.22 %Pass
LAL kinetic chromogenicBacterial endotoxin< 5.0 EU/mg< 0.61 EU/mgPass
USP <71> membrane filtrationSterilityNo growthNo growthPass
Visual / USP <790>AppearanceWhite to off-white cake, free of visible particulatesConformsPass

Sequence

Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH

Handling for this lot

Appearance
White lyophilised powder
Storage
-20 °C lyophilised; 2–8 °C reconstituted
Reconstitution
Dissolves rapidly. The N-terminal acetyl group is confirmed by mass on every lot — un-acetylated material is a common substitution.

Other lots of TB-500

Compare batch to batch. Consistency across lots is a stronger signal than any single certificate.

Research use only. This certificate describes material supplied strictly for laboratory research. It is not a drug, food, cosmetic or medical device, has not been evaluated by the FDA, and is not intended for human or veterinary administration of any kind.